AN 982
Alternative Names: Morphine-hydrochloride; OPSOLatest Information Update: 04 Apr 2022
Price :
$50 *
At a glance
- Originator Dainippon Sumitomo Pharma
- Developer Sumitomo Pharma
- Class Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cancer pain